SCHEMBL21756191

SCHEMBL21756191

CCN(CC)CCCc1ncc(-c2cc(-c3cc(Cl)ccc3F)nc3ncccc23)c2ccncc12

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 1/20 0.38
ACP1 P24666 1/20 0.36
TGFBR1 P36897 13/20 0.33
ACVR1B P36896 8/20 0.33
ACVRL1 P37023 7/20 0.33
PIM1 P11309 1/20 0.33
FLT3 P36888 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
RET P07949 1/20 0.33
LATS1 O95835 1/20 0.33
LATS2 Q9NRM7 1/20 0.33
CYP1A2 P05177 1/20 0.33
IDO1 P14902 1/20 0.32
KIT P10721 1/20 0.32
BMPR1A P36894 1/20 0.32
ACVR1 Q04771 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3379368 0.86 AGER (0.36) CCR4TGFBR1ACVR1BACVRL1PIM1
SCHEMBL3379888 0.82 AGER (0.38) CCR4TGFBR1ACVR1BACVRL1BMPR1A
SCHEMBL3385997 0.81 KDM4E (0.44) CCR4ACP1TGFBR1ACVR1BACVRL1
SCHEMBL21756156 0.80 TGFBR1 (0.39) TGFBR1ACVR1BACVRL1PIM1FLT3
SCHEMBL3390023 0.80 TGFBR1 (0.40) ACP1TGFBR1ACVR1BACVRL1PIM1
SCHEMBL3381872 0.80 HTR1A (0.38) CCR4TGFBR1ACVR1BACVRL1CYP1A2
SCHEMBL3383241 0.80 TGFBR1 (0.38) TGFBR1ACVR1BACVRL1PIM1FLT3
SCHEMBL247224 0.79 TBK1 (0.46) ACP1TGFBR1ACVR1BACVRL1PIM1
SCHEMBL3379333 0.79 IDO1 (0.39) TGFBR1ACVR1BACVRL1PIM1FLT3
SCHEMBL12440185 0.77 TGFBR1 (0.41) ACP1TGFBR1ACVR1BACVRL1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585461-B1 2,4-DIARYL-SUBSTITUTED [1,8]NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER MERCK PATENT GMBH (DE) 2020-02-26 EP disclosed